Market Shakeup in Developing Maternal Blood Prenatal Diagnostics

<p><a href="http://clk.about.com/?zi=1/1hc&#038;zu=http://www.illumina.com/">Illumina</a>, the leading provider of <a href="http://clk.about.com/?zi=1/1hc&#038;zu=http://biotech.about.com/od/researchlaboratory/a/The-Need-For-Cheaper-And-Faster-Dna-Sequencing.htm">high throughput gene sequencing</a> technology, announced <a href="http://clk.about.com/?zi=1/1hc&#038;zu=http://investor.illumina.com/phoenix.zhtml?c=121127&#038;p=irol-newsArticle&#038;ID=1771460&#038;highlight=">Monday</a> that it has agreed to purchase <a href="http://clk.about.com/?zi=1/1hc&#038;zu=http://www.verinata.com/patients/patients-overview/">Verinata Health</a>, who provide medical tests to determine fetal chromosomal abnormalities using a pregnant women's blood rather than invasive&#160;<a href="http://clk.about.com/?zi=1/1hc&#038;zu=http://pregnancy.about.com/od/amniocentesis/a/amniotest.htm">amniocentesis</a>.</p>...<p><a href="http://clk.about.com/?zi=1/1hc&#038;zu=http://biotech.about.com/b/2013/01/10/market-shakeup-in-developing-maternal-blood-prenatal-diagnostics.htm">Read Full Post</a></p>
Source: About.com Biotech Biomedical - Category: Biotechnology Source Type: news